🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Carlos Martı́n

Universidad de Zaragoza

ORCID: 0000-0003-2993-5478

Also affiliated with Instituto de Salud Carlos III, Hospital Universitari Sant Joan D'Alacant, Hospital Virgen de la Luz, Centro de Investigación Biomédica en Red de Enfermedades Respiratorias, Hospital Universitario Miguel Servet, Instituto Alexander Fleming, Hospital Marina Baixa

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “Respiratory Immunization With a Whole Cell Inactivated Vaccine Induces Functional Mucosal Immunoglobulins Against Tuberculosis in Mice and Non-human Primates”.

Respiratory Immunization With a Whole Cell Inactivated Vaccine Induces Functional Mucosal Immunoglobulins Against Tuberculosis in Mice and Non-human Primates

Frontiers in Microbiology(2020)10.3389/fmicb.2020.01339

N/A

0DataRank · unranked

16 citations

Santiago Uranga, Elena Mata, Raquel Tarancón, Ana Belén Gómez, Dessislava Marinova +11 more

Natural killer activation for bladder cancer elimination can be achieved in vitro by heat-killed BCG

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.06.04.129361

N/A

0DataRank · unranked

0 citations

Nacho Aguiló, Esther Julián, Omodele Ashiru, Mei Mei Ho, Carlos Martı́n +2 more

Stronger induction of trained immunity by mucosal BCG or MTBVAC vaccination compared to standard intradermal vaccination

Cell Reports Medicine(2021)10.1016/j.xcrm.2020.100185

N/A

0DataRank · unranked

97 citations

Karin Dijkman, Claudia C. Sombroek, Sam Hofman, Charelle Boot, Richard A. W. Vervenne +16 more

MTBVAC: A Tuberculosis Vaccine Candidate Advancing Towards Clinical Efficacy Trials in TB Prevention

Archivos de Bronconeumología(2023)10.1016/j.arbres.2023.09.009

N/A

0DataRank · unranked

23 citations

Carlos Martı́n, Sergio Lacámara

Live-attenuated Mycobacterium tuberculosis vaccine, MTBVAC, in adults with or without M tuberculosis sensitisation: a single-centre, phase 1b–2a, double-blind, dose-escalation, randomised controlled trial

The Lancet Global Health(2025)10.1016/s2214-109x(25)00046-4

N/A

0DataRank · unranked

17 citations

Virginie Rozot, Claire Imbratta, Frances Ratangee, Justin Shenje, Michèle Tameris +62 more

Safety, reactogenicity, and immunogenicity of MTBVAC in infants: a phase 2a randomised, double-blind, dose-defining trial in a TB endemic setting

EBioMedicine(2025)10.1016/j.ebiom.2025.105628

N/A

0DataRank · unranked

12 citations

Virginie Rozot, Claire Imbratta, Hennie Geldenhuys, Simon C. Mendelsohn, Angelique Kany Kany Luabeya +58 more